Andrew Cioffi

Andrew Cioffi is a seasoned professional with over 20 years of experience in the pharmaceutical industry, operating in Europe, Latin America, and Asia. He possesses a strong passion for launching new brands and holds a remarkable track record of successfully introducing 6 blockbuster pharmaceutical brands at local, regional, and global levels.

Specializing in strategic marketing, launch excellence, and team management, Andrew has a keen interest in developing and emerging markets, particularly excelling in areas like China, Asia, and Latin America. He is skilled in strategic analysis, sales, oncology, and virtual engagement platforms, contributing significantly to the growth and success of various organizations.

Andrew Cioffi's educational background includes a CIM Postgraduate Diploma in Marketing from the Chartered Institute of Marketing, an MBA in Marketing from Cranfield University - Cranfield School of Management, and a Bachelor of Pharmacy (Hons.) from L-Università ta' Malta.

His career journey features prominent roles such as Global Strategic Marketing Director at Bayer Pharmaceuticals, Global Marketing Director at AstraZeneca, and China Launch Leader at Roche. He has also held key positions within Roche, such as LATAM Business Leader for Breast Cancer and HER2 Franchises, LATAM Leader in Key Account Management, and Global Brand Manager for PERJETA. Additionally, Andrew's experience includes various strategic and analytical roles within Roche and Eli Lilly, showcasing his versatility and expertise in the pharmaceutical sector.

Andrew's professional expertise extends to launch acceleration, design thinking, and driving growth in both developed and developing markets. His career trajectory illustrates a consistent focus on innovation, strategic planning, and successful brand establishment, making him a distinguished leader in the pharmaceutical industry.